Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Verastem Oncology’s avutometinib plus defactinib trial in LGSOC published in JCO with robust clinical responses Verastem Oncology published pivotal Phase 2 RAMP 201 trial results in JCO, showing strong response rates for avutometinib plus defactinib in recurrent LGSOC. byPallavi MadhirajuJuly 13, 2025